NewLimit
Extending human healthspan.NewLimit is a biotechnology company working to radically extend human healthspan. They are developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells.
Work Type
Onsite
Stage
Series B
Industry
Biotech
Location
San Francisco, United States